Table 2

Expression of MTA3 mRNA and protein in the 118 NSCLC cases
Parameter MTA3 mRNA MTA3 protein
Expression level P value n P value
Negative Positive
Gender
  Male 0.2547 ± 0.10485 0.581 24 35 1.000
  Female 0.2442 ± 0.10298 24 35
Age (years)
  ≥60 0.2646 ± 0.09439 0.073 21 45 0.038*
  <60 0.2302 ± 0.11224 27 25
Histology
  Adeno 0.2444 ± 0.10711 0.534 29 40 0.849
  SCC 0.2565 ± 0.09913 19 30
Differentiation
  Well 0.2234 ± 0.11671 0.038* 28 18 0.001*
  Moderate-poor 0.2661 ± 0.09131 20 52
Tumor stage
  T1 0.2233 ± 0.10521 22 17 0.018*
  T2 0.2485 ± 0.10680 0.030* 21 34
  T3–4 0.2942 ± 0.07934 5 19
TNM stage
  I 0.2350 ± 0.10463 0.079 28 24 0.018*
  II 0.2435 ± 0.10970 15 27
  III 0.2913 ± 0.08077 5 19
Nodal status
  Positive 0.2810 ± 0.08593 0.003* 10 39 0.000*
  Negative 0.2270 ± 0.10969 38 31

*Indicated statistical significance (P < 0.05).

Zheng et al.

Zheng et al. Diagnostic Pathology 2013 8:166   doi:10.1186/1746-1596-8-166

Open Data